Enveda

Boulder, CO · Founded 2019 · Privately Held (backing)

Developer of a drug analysis platform designed to capitalize on the chemical diversity and evolutionary significance of natural samples. Enveda is based in Boulder, CO and was founded in 2019. It was valued at $2 billion at its Series E in Sep 2026, the last priced event on record. It has raised $530 million across 1 recorded round; the latest was a $311 million Series E in Sep 2026.

PMV mark · valuation
$2.0B
Oct 2026
Priced at
its Series E
Sep 2026
Total raised
$530.0M
Last round
Series E
Sep 2026
What is Enveda worth?
$2.0BPrivateMarketView mark · Oct 2026

Valued at $2.0B at its Series E, Sep 2026. Nothing has traded since.

Free account
More of Enveda with a free account
  • ·The post-money valuation on its round
  • ·The complete investor list: 47 names
  • ·Watch Enveda: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

1 priced round · 27 daily marks since · Sep 2026 – Oct 2026
▮▮
Series Erounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Enveda funding history

1 rounds
DateRoundRaisedPost-money
Sep 2026Series E$311.0M▮
Unlock post-money valuations

Membership and data by Private Market View

Enveda valuation

Enveda was valued at $2 billion at its Series E in Sep 2026. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

Recent activity

In the last 90 days, Enveda's record added 1 funding round.

How much has Enveda raised?

Enveda has raised $530 million in total; 1 of its rounds is on record. The largest on record was a $311 million Series E in Sep 2026. 1 of the rounds disclosed a post-money valuation.

How Enveda's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Enveda, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →

Frequently asked about Enveda

What is Enveda worth?
Enveda is valued at $2.0B as of Oct 2026. Valued at $2.0B at its Series E, Sep 2026. Nothing has traded since.
How much has Enveda raised?
Enveda has raised $530.0M in total funding across 1 recorded rounds.
When did Enveda last raise?
Enveda last raised in Sep 2026 (Series E), raising $311.0M.